Cargando…
Personalized management of cirrhosis by non-invasive tests of liver fibrosis
Owing to the high prevalence of various chronic liver diseases, cirrhosis is one of the leading causes of morbidity and mortality worldwide. In recent years, the development of non-invasive tests of fibrosis allows accurate diagnosis of cirrhosis and reduces the need for liver biopsy. In this review...
Autores principales: | Wong, Grace Lai-Hung, Espinosa, Wendell Zaragoza, Wong, Vicnent Wai-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612280/ https://www.ncbi.nlm.nih.gov/pubmed/26523265 http://dx.doi.org/10.3350/cmh.2015.21.3.200 |
Ejemplares similares
-
Non-invasive tests of non-alcoholic fatty liver disease
por: Li, Guanlin, et al.
Publicado: (2022) -
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and
future
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2023) -
Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
por: Wong, Grace Lai-Hung
Publicado: (2013) -
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests
por: Boursier, Jérôme, et al.
Publicado: (2023) -
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
por: Wai, Janae Wentong, et al.
Publicado: (2020)